Indoleamine 2,3 dioxygenase and metabolic control of immune responses

Munn, David H., Mellor, Andrew L.·2013·Trends in Immunology
DOI 10.1016/j.it.2012.10.001

Cited by (1,000)

Items 201–300 of 1,000

  1. Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
    Madhav D. Sharma, Rafał Pacholczyk, Huidong Shi, Zuzana Berrong, Yousef Zakharia, Austin Greco, Chang-Sheng S. Chang, Sudharshan Eathiraj, Eugene Paul Kennedy, Thomas Cash et al. · 2021 · Immunity
  2. Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody
    Andrés López‐Albaitero, Hong Xu, Hong-Fen Guo, Linlin Wang, Zhihao Wu, Hoa Tran, Sarat Chandarlapaty, Maurizio Scaltriti, Yelena Yuriy Janjigian, Elisa de Stanchina et al. · 2017 · OncoImmunology
  3. Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review
    Vilim Molnar, Eduard Pavelić, Kristijan Vrdoljak, Martin Čemerin, Emil Klarić, Vid Matišić, Roko Bjelica, Petar Brlek, Ivana Kovačić, Carlo Tremolada et al. · 2022 · Genes
  4. The good and bad of antioxidant foods: An immunological perspective
    Johanna Maria Gostner, Kathrin Becker, Florian Ueberall, Dietmar Fuchs · 2015 · Food and Chemical Toxicology
  5. GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology
    Haiyun Liu, Lei Huang, Jillian Bradley, Kebin Liu, Kankana Bardhan, David Ron, Andrew L. Mellor, David H. Munn, Tracy L. McGaha · 2013 · Molecular and Cellular Biology
  6. Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
    Anke Redeker, Ramon Arens · 2016 · Frontiers in Immunology
  7. Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c + Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation
    Tonia Woodberry, Jessica R. Loughland, Gabriela Minigo, Julie G. Burel, Fiona H. Amante, Kim A. Piera, Yvette McNeil, Tsin Wen Yeo, Michael F. Good, Denise L. Doolan et al. · 2017 · Infection and Immunity
  8. Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients
    John D. Sinden, Caroline A. Hicks, Paul Stroemer, Indira Vishnubhatla, Randolph L. Corteling · 2017 · Stem Cells and Development
  9. Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma
    Yasuo Takashima, Atsushi Kawaguchi, Tomohiko Kanayama, Azusa Hayano, Ryuya Yamanaka · 2018 · Oncotarget
  10. Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)
    Yu Yu, Jiuwei Cui · 2018 · Oncology Letters
  11. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer
    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami, Mehrdad Fathi, Mehran Mohammadpour Saray, Leili Aghebati Maleki, Reza Jafari, Naime Majidi Zolbanin, Farhad Jadidi‐Niaragh · 2021 · Life Sciences
  12. Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies
    Binghan Zhou, Yuan Gao, Peng Zhang, Qian Chu · 2021 · Frontiers in Immunology
  13. Plasma Tryptophan and the Kynurenine–Tryptophan Ratio are Associated with the Acquisition of Statural Growth Deficits and Oral Vaccine Underperformance in Populations with Environmental Enteropathy
    Margaret N. Kosek, Estomih Raphael Mduma, Peter S. Kosek, Gwenyth O. Lee, Erling Svensen, William K. Pan, Maribel Paredes Olórtegui, Jay H. Bream, Crystal L. Patil, César Ramal Asayag et al. · 2016 · American Journal of Tropical Medicine and Hygiene
  14. Inhibition of acute lethal pulmonary inflammation by the IDO–AhR pathway
    Soung-Min Lee, Ha Young Park, Young-Sill Suh, Eun Hye Yoon, Juyang Kim, Won Hee Jang, Won-Sik Lee, Sae-Gwang Park, Il‐Whan Choi, Inhak Choi et al. · 2017 · Proceedings of the National Academy of Sciences
  15. B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm
    Basil W. Schaheen, Emily Downs, Vlad Serbulea, Camila Cruz Pereira Almenara, Michael D. Spinosa, Gang Su, Yunge Zhao, Prasad Srikakulapu, Cherié L. Butts, Coleen A. McNamara et al. · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
  16. Disturbed lipid and amino acid metabolisms in COVID-19 patients
    Mojgan Masoodi, Manuela Peschka, Stefan Schmiedel, Munif Haddad, Maike Frye, Coen Maas, Ansgar Wilhelm Lohse, Samuel Huber, Paulus F. Kirchhof, Jerzy–Roch Nofer et al. · 2022 · Journal of Molecular Medicine
  17. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
    André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, Xiangsheng Liu · 2022 · ACS Nano
  18. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship
    Perrine Bortolotti, Benjamin Hennart, Camille Thieffry, Guillaume Jausions, Emmanuel Faure, Teddy Grandjean, Marion Thépaut, Rodrigue Dessein, Delphine Allorge, Benoit P. Guery et al. · 2016 · BMC Microbiology
  19. T cells encountering myeloid cells programmed for amino acid-dependent immunosuppression use Rictor/mTORC2 protein for proliferative checkpoint decisions
    Van de Velde, Lee-Ann, Subramanian, Chitra, Smith, Amber M., Barron, Luke, Qualls, Joseph E., Neale, Geoffrey, Alfonso-Pecchio, Adolfo, Jackowski, Suzanne, Rock, Charles O., Wynn, Thomas A. et al. · 2017 · Journal of Biological Chemistry
  20. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder
    Masashi Sakurai, Yasuko Yamamoto, Noriyo Kanayama, Masaya Hasegawa, Akihiro Mouri, Masao Takemura, Hidetoshi Matsunami, Tomoya Miyauchi, Tatsuya Tokura, Hiroyuki Kimura et al. · 2020 · Scientific Reports
  21. Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
    Melita B. Irving, Romain Vuillefroy de Silly, Kirsten B. J. Scholten, Nahzli Dilek, George Coukos · 2017 · Frontiers in Immunology
  22. Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy
    Shu‐Yu Lin, Teng‐Kuang Yeh, Ching‐Chuan Kuo, Jen‐Shin Song, Ming-Fu Cheng, Fang-Yu Liao, Min‐Wu Chao, Han-Li Huang, Yi-Lin Chen, Chun-Yu Yang et al. · 2015 · Journal of Medicinal Chemistry
  23. HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
    Rindert Missiaen, Nicholas P. Lesner, Marie Celeste Simon · 2023 · The EMBO Journal
  24. The role of indoleamine‐2,3‐dioxygenase in normal and pathological pregnancies
    Ruiqi Chang, Da‐Jin Li, Ming‐Qing Li · 2017 · American Journal of Reproductive Immunology
  25. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors
    Florence Schramme, Stefano Crosignani, Kim Frederix, Delia Hoffmann, Luc Pilotte, Vincent Stroobant, Julie Preillon, Grégory Driessens, Benoit J. Van den Eynde · 2019 · Cancer Immunology Research
  26. Long Noncoding RNAs, New Critical Regulators in Cancer Immunity
    Minjie Wu, Peifen Fu, Lei Qu, Jian Liu, Aifu Lin · 2020 · Frontiers in Oncology
  27. Tryptophan: From Diet to Cardiovascular Diseases
    Nada Joe Melhem, Soraya Taleb · 2021 · International Journal of Molecular Sciences
  28. Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
    Feifei Li, Xia Guo, Shi‐You Chen · 2017 · Frontiers in Cardiovascular Medicine
  29. Salmonella -Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors
    Edwin Ramos Manuel, Jeremy Chen, Massimo D’Apuzzo, Melanie G. Lampa, Teodora I. Kaltcheva, Curtis B. Thompson, Thomas Ludwig, Vincent M. Chung, Don J. Diamond · 2015 · Cancer Immunology Research
  30. Regulatory T cell therapy for type 1 diabetes: May the force be with you
    Stephen Eric Gitelman, Jeffrey A. Bluestone · 2016 · Journal of Autoimmunity
  31. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
    Yufei Wang, Anna Jia, Yujing Bi, Yuexin Wang, Guangwei Liu · 2020 · Cells
  32. Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
    Ute F. Röhrig, Somi Reddy Majjigapu, Marc Chambon, Sylvian Bron, Luc Pilotte, Didier Colau, Benoit J. Van den Eynde, Gerardo Turcatti, Pierre Vogel, Vincent Zoete et al. · 2014 · European Journal of Medicinal Chemistry
  33. Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
    Elisa Albini, V. Rosini, Marco Gargaro, Giada Mondanelli, Maria Laura Belladonna, Maria Teresa Pallotta, Claudia Volpi, Francesca Fallarino, Antonio Macchiarulo, Cinzia Antognelli et al. · 2016 · Journal of Cellular and Molecular Medicine
  34. Dysregulation of Tryptophan Catabolism in Metabolic Syndrome
    Neila Hiraishi Mallmann, Émerson Silva Lima, Pritesh Jaychand Lalwani · 2018 · Metabolic Syndrome and Related Disorders
  35. Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues
    Ravikumar Muthuswamy, Nana J. Okada, Frank J. Jenkins, Kandace P. McGuire, Priscilla F. McAuliffe, Herbert J. Zeh, David L. Bartlett, Callen T. Wallace, Simon C. Watkins, Jill D. Henning et al. · 2017 · Brain Behavior and Immunity
  36. Role of tryptophan metabolism in cancers and therapeutic implications
    Xiaohan Liu, Xiao‐Yue Zhai · 2021 · Biochimie
  37. Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms
    Johanna Maria Gostner, Kathrin Becker, Katharina Kurz, Dietmar Fuchs · 2015 · Frontiers in Psychiatry
  38. TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
    Roberta Angioni, Ricardo Sánchez‐Rodríguez, Antonella Viola, Barbara Molon · 2021 · Cancers
  39. Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies
    Yi Xia, Leonard Jeffrey Medeiros, Ken H. Young · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  40. The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs
    Fabián Salazar, Dennis Awuah, Ola H. Negm, Farouk Shakib, Amir M. Ghaemmaghami · 2017 · Scientific Reports
  41. Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
    Wamidh H. Talib, Ahmad Riyad Alsayed, Faten Farhan, Lina Tariq Al Kury · 2020 · Molecules
  42. Pathogenetic Features and Current Management of Glioblastoma
    Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe, Dipongkor Saha · 2021 · Cancers
  43. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
    Giuseppina Bonanno, Andrea Mariotti, Annabella Procoli, Valentina Folgiero, Daniela Natale, Luca De Rosa, Ignazio Majolino, Linda Novarese, Alberto Rocci, Manuela Gambella et al. · 2012 · Journal of Translational Medicine
  44. Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis –Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling
    Babak Memari, Manuella Bouttier, Vassil Dimitrov, Marc Ouellette, Marcel A. Behr, Jorg H Fritz, John H. White · 2015 · The Journal of Immunology
  45. The relevance of functional amino acids to support the health of growing pigs
    Nathalie Le Floc'H, Anna Grete Wessels, E. Corrent, Guoyao Wu, Paolo Bosi · 2018 · Animal Feed Science and Technology
  46. Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
    Cai, Xin, Zhan, Huajie, Ye, Yuguang, Yang, Jinjin, Zhang, Minghui, Li, Jing, Zhuang, Yuan · 2021 · Frontiers in Genetics
  47. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression
    Chutima Roomruangwong, George Anderson, Michael Berk, Drozdstoy Stoyanov, Andre Ferrer Carvalho, Michael H. J. Maes · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  48. Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
    Kenji Tsuji, Shinji Kitamura, Jun Wada · 2018 · Stem Cells International
  49. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection
    M‐A Jenabian, M Patel, Ido P. Kema, Kishanda Vyboh, Cynthia Kanagaratham, Danuta Radzioch, Paméla Thébault, Réjean Lapointe, Norbert J. Gilmore, Petronela Ancuța et al. · 2014 · Clinical & Experimental Immunology
  50. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes
    Joe M. Horvatinovich, Elizabeth W. Grogan, Marcus S. Norris, Alexander Steinkasserer, Henrique de Paula Lemos, Andrew L. Mellor, Irina Y. Tcherepanova, Charles A. Nicolette, Mark A. Debenedette · 2017 · The Journal of Immunology
  51. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
    Valentina Audrito, Antonella Managò, Federica Gaudino, Leonardo Sorci, Vincenzo Gianluca Messana, Nadia Raffaelli, Silvia Deaglio · 2019 · Frontiers in Immunology
  52. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
    Alok Kumar, Kenji Chamoto, Partha Sarathi Chowdhury, Tasuku Honjo · 2020 · eLife
  53. Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer
    Martina Mandarano, Elena Orecchini, Guido Bellezza, Jacopo Vannucci, Vienna Ludovini, Sara Baglivo, Francesca Romana Tofanetti, Rita Chiari, Elisabetta Loreti, Francesco Puma et al. · 2021 · International Journal of Molecular Sciences
  54. Diverse Mechanisms Regulate the Surface Expression of Immunotherapeutic Target CTLA-4
    Helga Schneider, Christopher E. Rudd · 2014 · Frontiers in Immunology
  55. IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
    Marina Teresita Isla Larrain, Martín Enrique Rabassa, Ezequiel Lacunza, A. Barbera, Aldo Cretón, Amada Segal‐Eiras, María Virginia Croce · 2014 · Tumor Biology
  56. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome
    Naomi I. Maria, Cornelia G van Helden-Meeuwsen, Zana Brkić, Sandra M. J. Paulissen, Eline C. Steenwijk, Virgil A. S. H. Dalm, Paul L. A. van Daele, P. Martin van Hagen, Frans G. M. Kroese, Joël A. G. van Roon et al. · 2016 · Arthritis & Rheumatology
  57. Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression
    Martha de Oliveira Bravo, Juliana Lott Carvalho, Felipe Saldanha‐Araújo · 2016 · Purinergic Signalling
  58. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson’s Disorder and Therapeutic Implications
    Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Saurabh Bhatia, Ahmed Al‐Harrasi, Gökhan Zengin, Adrian Gheorghe Bumbu, Felicia Liana Andronie-Cioară, Aurelia Cristina Nechifor et al. · 2021 · International Journal of Molecular Sciences
  59. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
    Francesca Hofer, G. Di Sario, C. Musiu, S. Sartoris, F. De Sanctis, S. Ugel · 2021 · Cells
  60. Endometrial Microbiota and Immune Tolerance in Pregnancy
    Annalisa Inversetti, Enrica Zambella, Alice Guarano, Marinella Dell’avanzo, Nicoletta Di Simone · 2023 · International Journal of Molecular Sciences
  61. Indoleamine 2,3-Dioxygenase Activity Contributes to Local Immune Suppression in the Skin Expressing Human Papillomavirus Oncoprotein E7
    Deepak Mittal, Andrew J. Kassianos, Le Son Tran, Anne‐Sophie Bergot, Christine Gosmann, Janin Hofmann, Antje Blumenthal, Graham Robert Leggatt, Ian Hector Frazer · 2013 · Journal of Investigative Dermatology
  62. A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma
    David A. Reardon, Annick Desjardins, Olivier Rixe, Timothy Francis Cloughesy, Shilpa Alekar, Jason H. Williams, Ray Li, Carrie Turich Taylor, Andrew B. Lassman · 2020 · Investigational New Drugs
  63. Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid
    Hirohito Haruki, Ruud Hovius, Miriam Grønlund Pedersen, Kai Johnsson · 2015 · Journal of Biological Chemistry
  64. Development of simultaneous analysis of tryptophan metabolites in serum and gastric juice – an investigation towards establishing a biomarker test for gastric cancer diagnosis
    Jong Min Choi, Won Sang Park, Kyo Young Song, Hwa Jeong Lee, Byung Hwa Jung · 2016 · Biomedical Chromatography
  65. Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation
    Isabell Adam, Dyah Laksmi Dewi, Joram Mooiweer, Ahmed Sadik, Soumya R. Mohapatra, Bianca Berdel, Melanie Keil, Jana K. Sonner, Kathrin Thedieck, Adam J. Rose et al. · 2018 · OncoImmunology
  66. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?
    Lisa Pleyer, Peter Valent, Richard Greil · 2016 · International Journal of Molecular Sciences
  67. Berberine-induced TFEB deacetylation by SIRT1 promotes autophagy in peritoneal macrophages
    Yinghong Zheng, Jiayuan Kou, Pengyu Wang, Ting Ye, Zitong Wang, Ziyu Gao, Lin Cong, Manman Li, Bowen Dong, Wei Ping Yang et al. · 2021 · Aging
  68. Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer
    Jodi M. Carter, Mei‐Yin C. Polley, Roberto Antonio Leon-Ferre, Jason P. Sinnwell, Kevin J. Thompson, Xue Wang, Yaohua Ma, David Zahrieh, Jennifer M. Kachergus, Malvika H. Solanki et al. · 2021 · Clinical Cancer Research
  69. Metabolic Reprogramming in COVID-19
    Tao Shen, Tingting Wang · 2021 · International Journal of Molecular Sciences
  70. Glycolysis in Innate Immune Cells Contributes to Autoimmunity
    Yue Xu, Yongkang Chen, Xuan Zhang, Jie Ma, Yudong Liu, Liyan Cui, Fang Wang · 2022 · Frontiers in Immunology
  71. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry
    Teresa T. Nguyen, Dong Ho Shin, Sagar Shashikant Sohoni, Sanjay Kumar Singh, Yisel A. Rivera-Molina, Hong Jiang, Xuejun Fan, Joy Gumin, Frederick F. Lang, Christopher A Alvarez-Breckenridge et al. · 2022 · Journal for ImmunoTherapy of Cancer
  72. Pre-treatment effects of peripheral tumors on brain and behavior: Neuroinflammatory mechanisms in humans and rodents
    Andrew Schrepf, Susan K. Lutgendorf, Leah M. Pyter · 2015 · Brain Behavior and Immunity
  73. Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways
    Arum Park, Yunjeong Yang, Yunhee Lee, Mi Sun Kim, Young‐Jun Park, Haiyoung Jung, Tae‐Don Kim, Hee Gu Lee, Inpyo Choi, Suk Ran Yoon · 2019 · Journal of Clinical Medicine
  74. The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases
    Xiaowen Zheng, Yi Zhu, Zihan Zhao, Ying Chu, Wenjing Yang · 2023 · Frontiers in Immunology
  75. Function of reactive oxygen species in myeloid-derived suppressor cells
    Jiaojiao Huang, Yue Zhao, Kexin Zhao, Kai Yin, Shengjun Wang · 2023 · Frontiers in Immunology
  76. Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP)
    Anita C. A. Dankers, Henricus A. M. Mutsaers, Henry B P M Dijkman, Lambertus P. van den Heuvel, Joost G.J. Hoenderop, Fred C.G.J. Sweep, Frans G. M. Rüssel, Rosalinde Masereeuw · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  77. Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
    Fanni Annamária Boros, László Vécsei · 2019 · Frontiers in Immunology
  78. Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
    Benjamin Heng, AYSE AYSIN BOMBACI BILGIN, David B. Lovejoy, Vanessa X. Tan, Heloisa Helena Milioli, Laurence Gluch, Sonia Bustamante, Tharani Sabaretnam, Pablo Moscato, Chai K. Lim et al. · 2020 · Breast Cancer Research
  79. Immunometabolism in cancer: basic mechanisms and new targeting strategy
    Ranran Su, Yingying Shao, Manru Huang, Donghui Liu, Haiyang Yu, Yuling Qiu · 2024 · Cell Death Discovery
  80. For when bacterial infections persist: Toll-like receptor-inducible direct antimicrobial pathways in macrophages
    Claudia J. Stocks, Mark A. Schembri, Matthew J. Sweet, Ronan Kapétanovic · 2018 · Journal of Leukocyte Biology
  81. The weight of nutrients: kynurenine metabolites in obesity and exercise
    Shamim Dadvar, Duarte M. S. Ferreira, Igor Červenka, Jorge Lira Ruas · 2018 · Journal of Internal Medicine
  82. Expression of immune checkpoint receptors Indoleamine 2,3‐dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
    Gustav Stålhammar, Stefan Seregard, Hans E. Grossniklaus · 2019 · Cancer Medicine
  83. Understanding Metabolic Regulation Between Host and Pathogens: New Opportunities for the Development of Improved Therapeutic Strategies Against Mycobacterium tuberculosis Infection
    Ji-Hae Park, Dahee Shim, Keu Eun San Kim, Wonsik Lee, Sung Jae Shin · 2021 · Frontiers in Cellular and Infection Microbiology
  84. The interplay between metabolic remodeling and immune regulation in glioblastoma
    Pravin Kesarwani, Shiva Kant, Antony Herold Prabhu, Prakash Chinnaiyan · 2017 · Neuro-Oncology
  85. Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes
    Florence Anquetil, Giada Mondanelli, Nathaly Gonzalez, Teresa Rodriguez Calvo, Jose Zapardiel‐Gonzalo, Lars Krogvold, Knut Dahl‐Jørgensen, Benoit J. Van den Eynde, Ciriana Orabona, Ursula Grohmann et al. · 2018 · Diabetes
  86. Emerging role for kynurenines in metabolic pathologies
    Junjun Liu, Jamileh Movassat, Bernard Portha · 2018 · Current Opinion in Clinical Nutrition & Metabolic Care
  87. Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy
    Philipp Zimmer, Martina E. Schmidt, Mirja Tamara Prentzell, Bianca Berdel, Joachim Wiskemann, Karl Heinz Kellner, Jürgen Debus, Cornelia M. Ulrich, Christiane A. Opitz, Karen Steindorf · 2019 · Frontiers in Oncology
  88. Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
    Quan Zhuang, Haozheng Cai, Qingtai Cao, Zixin Li, Shu Liu, Yingzi Ming · 2020 · Frontiers in Immunology
  89. Adipose‐derived stromal cells for nonhealing wounds: Emerging opportunities and challenges
    Milena Deptuła, Agnieszka Brzezicka, Aneta Skoniecka, Jacek Zieliński, Michał Pikuła · 2021 · Medicinal Research Reviews
  90. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
    Zhenqing Wang, Liang Chen, Yiqun Ma, Xilei Li, Annan Hu, Wenxing Wang, Wenxing Wang, Xiaomin Li, Bo Tian, Jian Dong · 2021 · Journal of Nanobiotechnology
  91. Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
    Steven Zhao, Ronal M. Peralta, Natalia Avina-Ochoa, Greg M. Delgoffe, Susan M. Kaech · 2021 · Seminars in Immunology
  92. Natural products and their derivatives as immune check point inhibitors: Targeting cytokine/chemokine signalling in cancer
    Meenakshi Gupta, Kumari Chandan, Maryam Sarwat · 2022 · Seminars in Cancer Biology
  93. Immune profiling of pediatric solid tumors
    Rachael L. Terry, Déborah Meyran, David Simon Ziegler, Michelle Haber, Paul G. Ekert, Joseph A. Trapani, Paul Joseph Neeson · 2020 · Journal of Clinical Investigation
  94. Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis
    Shengchao Zhang, Jiankai Fang, Zhanhong Liu, Pengbo Hou, Lijuan Cao, Yuyan Zhang, Rui Liu, Yanan Li, Qianwen Shang, Yongjing Chen et al. · 2021 · Stem Cell Research & Therapy
  95. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder
    Flurin Cathomas, Karoline Guetter, Erich Seifritz, Federica Klaus, Stefan Kaiser · 2021 · Scientific Reports
  96. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies
    Hamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ali Akbar Samadani, Mehryar Habibi Roudkenar · 2022 · Medical Oncology
  97. Are mesenchymal stromal cells immune cells?
    Martin Johannes Hoogduijn · 2015 · Arthritis Research & Therapy
  98. Tuning cancer fate: the unremitting role of host immunity
    Bianca Calì, Barbara Molon, Antonella Viola · 2017 · Open Biology
  99. The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis
    Sen Wang, Jia Wu, Han Shen, Junjun Wang · 2020 · BMC Cancer
  100. The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19
    Arianna Di Stadio, Claudio Costantini, Giorgia Renga, Marilena Pariano, Giampietro Ricci, Luigina R. Romani · 2020 · Life